Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the prognostic influence of light rheography measurement at the fingertips from subjects with secundary Raynaud syndrome.


Clinical Trial Description

Digital Ulcers (DU) belong to one of the most prevalent complications of systemic scleroses, leading in course to considerable impairment in everyday and professional life. The aetiology of the emergence of DU in patients with systemic scleroses (SSc) is complex, whereas the disease itself is primarily characterized by a vasculopathy of the small arterial vessels. In the course of the disease this chronic infection leads to fibrotic intimal hyperplasia, adventitial fibrosis, and thus to a significant lumen narrowing. So far, a number of independent risk factors have been identified, such as male gender, chronic infections of the esophagus, pulmonary-arterial hypertension, evidence of specific antibodies (e.g. anti-Scl70) in the blood, or the a previous manifestation of a Raynoud Syndrom. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01378845
Study type Interventional
Source University of Freiburg
Contact Christoph Hehrlein, Prof. Dr. med.
Phone +49 761 270 77090
Email christoph.hehrlein@uniklinik-freiburg.de
Status Recruiting
Phase N/A
Start date July 2011
Completion date September 2015

See also
  Status Clinical Trial Phase
Completed NCT00946738 - The Effect of Physical Therapy on Raynaud`s Phenomenon Secondary to Systemic Sclerosis N/A
Completed NCT02050360 - "As Required" Oral Sildenafil in Raynaud's Phenomenon Phase 2/Phase 3
Completed NCT01117298 - A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma Phase 3
Completed NCT02583789 - Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon Early Phase 1
Terminated NCT01315899 - Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon Phase 2
Completed NCT03058887 - The Effects of Exercise in Patients With Systemic Sclerosis N/A
Completed NCT00700518 - Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon Phase 1
Completed NCT02506062 - A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP) N/A
Completed NCT00841594 - MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison Phase 1